Finoriq research workspace
Aspire Biopharma Holdings, Inc. (ASBP) SEC Filings & Filing Highlights
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets. Review ASBP SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
- Company
- Aspire Biopharma Holdings, Inc. (ASBP)
- Ticker
- ASBP
- Market Cap
- $8.5M
- Latest Price
- $6.55
- Industry
- Biotech & Pharma
Aspire Biopharma Holdings, Inc. (ASBP) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Aspire Biopharma Holdings, Inc. (ASBP).
| Event | Form | Date |
|---|---|---|
| Broker Non-VotesOn June 16, 2026, at the Special Meeting of Stockholders (the “Meeting”) of Aspire Biopharma Holdings, Inc. (the “Company”), the Company’s... | 8-K5.07 | 2026-06-22 |
| Aspire to acquire 100% of DCS for a total cash purchase price of $30 millionAspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automoti... | 8-K7.01 | 2026-06-12 |
| Purchase AgreementOn June 10, 2026, Aspire Biopharma Holdings, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with FireFis... | 8-K1.01 | 2026-06-12 |
| Date: June 12, 2026On June 9, 2026, the Company adjourned its shareholder meeting as a result of not reaching the quorum. The Company adjourned the meeting an... | 8-K8.01 | 2026-06-12 |
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K5.03 | 2026-05-14 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.